Research of hydroxycitric acid use feasibility for the carbohydrate metabolism disorders correction due to experimental insulin resistance in rats
DOI:
https://doi.org/10.24959/ubphj.16.69Keywords:
hydroxycitric acid, insulin resistance, glucose homeostasis, glycated hemoglobin, fructosamineAbstract
The article presents the study results of appropriateness of hydroxycitric acid use for the correction of pathological changes in carbohydrate metabolism formed during experimental insulin resistance in rats. It is revealed that the test compound substantially inhibits the formation of hyperglycemia and hyperinsulinemia. It also normalizes glucose homeostasis and reduces the content of glycosylation products.
References
Buren J. Dexamethasone decreases GLUT 1 and GLUT4 content in primary cultured rat adipocytes / J. Buren, J. Ereksson // Diabetol. ‒ 1999. ‒ Vol. 42, № 1. ‒ Р. 170.
Pankiv V. I. Laboratory Diagnosis of Carbohydrate Metabolism Disorders. Diagnosis Algorithm in Hyperglycemic States / V. I. Pankiv //International Journal of endocrinology – 2014. – №. 3.59. – P. 69-72.
Putilina FE, Zoidze SD. Methods of biochemical research (lipid and energy metabolism). Underеd. Prokhorova MI. Leningrad: Publishing House of Leningrad University, 1982. P. 168-172. (In Russian).
Vasques C. A. R. Hypolipemic effect of Garcinia cambogia in obese women / C. A. Vasques, R. Schneider, L. C. Klein‐Júnior // Phytotherapy Research. – 2014. – Vol. 28. – №. 6. – P. 887-891.
Westerink J. Pharmacological and non-pharmacological interventions to influence adipose tissue function / Westerink J., Visseren F. L. //Cardiovascular diabetology. – 2011. – Т. 10. – №. 1. – Р. 13-19.
Zagayko A. L. The impact of hydroxycitric acid on the lipid metabolism profile under experimental insulin resistance syndrome of Syrian hamsters / A. L. Zagayko, A. I. Shkapo, V. P. Fylymonenko, T. O. Briukhanova //Ukrainian Biochemical Journal. – 2016. – Vol. 88,№ 3. – P. 78-82.
Барна О. Н. Гликозилированный гемоглобин–надежный и точный тест для управления сахарным диабетом? / О. Н. Барна //Ліки України. – 2014. – №. 2. – С. 17-21.
Гульчій М. В. Системний контроль глікозильованого гемоглобіну—шлях до покращання лікування і якості життя людей з цукровим діабетом / М. В. Гульчій //Діабет. Ожиріння. Метаболічний синдром. – 2014. – №. 4. – С. 91-98.
Інформаційний лист «Модифікація методу моделювання експериментальної інсулінорезистентності у щурів» // А.Л. Загайко, Т.О. Брюханова, А.І. Шкапо. – К., №86-2015. – 7 с.
Королюк О. Я., Радченко О. М. Прогностичне значеня критеріїв метаболічного синдрому у хворих на ІХС із Уперше виявленою гіперглікемією / О. Я. Королюк, О. М. Радченко //Практикуючий лікар. – 2013. – №. 4. – С. 46-50.
Сыволап В.Д. Инсулинорезистентность: механизмы развития, возможности коррекции / Сыволап В.Д. //Запорожский медицинский журнал. – 2009. – №. 1. – С. 56-62.
Downloads
Published
Issue
Section
License
Copyright (c) 2016 National University of Pharmacy
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
